-
Symbol
-
TELO on Nasdaq
-
Investment type
-
Equity / Common Stock, no par value
-
Latest Disclosed Shares Owned
-
3,245,000 shares
-
Security Ownership %
-
9.4%
John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity ownership in Telomir Pharmaceuticals, Inc. Common Stock, no par value (TELO)
12 Feb 2026 - John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,245,000 shares of Telomir Pharmaceuticals, Inc. Common Stock, no par value (TELO).
This represents 9.4% ownership of the company.
In their previous filing dated 18 Sep 2025, John Paul DeJoria had reported owning 1,774,900 shares, indicating an increase of +83%.
.